Journey Medical DERM
NASDAQ DERM
$4.52 +0.05 (+1.12%)
At close: Nov 9, 2026 · 4:00 PM EST

Journey Medical (DERM) Asset Writedowns and Impairment (2023)

Updated

Journey Medical (DERM) recorded Asset Writedowns and Impairment of $3.14 million in FY2023.

Analysis

Journey Medical (DERM) Asset Writedowns and Impairment (2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn
5 Novartis Ag 316.85 Bn 290.09 Bn -
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn
10 Journey Medical 123.72 Mn 21.81 Mn 12.37 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 3.14 Mn
API Access

Journey Medical Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=DERM&period=max&api_key=YOUR_API_KEY